ORLANDO, FL / ACCESSWIRE / December 9, 2022 / RedChip Companies will air a new interview with Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with unmet medical needs, on The RedChip Money Report® on Bloomberg TV, this Saturday, December 10, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Interview highlights:
In the exclusive RedChip Money Report interview, Unicycive’s CEO Shalabh Gupta discusses the Company’s lead program for hyperphosphatemia, expected data from the bioequivalence study, the upcoming Phase 1 trial, and much more.
Access this interview in its entirety at https://www.uncyinfo.com/interview_access
About The RedChip Money Report®
The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm…